Ftse Mib
38.348,16
-0,53%
DAX
22.433,63
-1,88%
S&P 500
6.144,15
0,24%
NASDAQ
20.056,25
0,07%
Bitcoin
97.105,16
0,49%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Conduit Pharmaceuticals Inc (CDTTW) Conduit Pharmaceuticals Inc (CDTTW) Notizie

Conduit Pharmaceuticals Inc

CDTTW
0,0112
-0,00265 (-19,11%)
19 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/2/202522:15EDGAR2Form 8-K - Current report
19/2/202515:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202523:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
11/2/202514:00EDGAR2Form 8-K - Current report
10/2/202522:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/2/202523:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/2/202514:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/2/202523:30EDGAR2Form S-3 - Registration statement under Securities Act of..
23/1/202514:15EDGAR2Form 8-K - Current report
21/1/202523:00EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
15/1/202522:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/1/202522:45EDGAR2Form 8-K - Current report
20/12/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202423:00EDGAR2Form 8-K - Current report
17/12/202423:15EDGAR2Form 8-K - Current report
09/12/202414:30EDGAR2Form DEF 14A - Other definitive proxy statements
09/12/202412:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/11/202423:21EDGAR2Form PRE 14A - Other preliminary proxy statements
25/11/202423:10EDGAR2Form S-3 - Registration statement under Securities Act of..
25/11/202422:53EDGAR2Form 8-K - Current report
20/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202423:00EDGAR2Form 8-K - Current report
14/11/202423:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202423:24EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
14/11/202423:22EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
14/11/202423:20EDGAR2Form 8-K - Current report
06/11/202412:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
04/11/202423:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/11/202423:20EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/11/202422:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/11/202421:15EDGAR2Form 8-K - Current report
28/10/202422:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/10/202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202412:12EDGAR2Form S-3 - Registration statement under Securities Act of..
18/10/202422:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/10/202423:15EDGAR2Form PRE 14A - Other preliminary proxy statements
15/10/202423:00EDGAR2Form 8-K - Current report
08/10/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202401:36EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
02/10/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202422:21GLOBEA Presidio Property Trust Major Investment To Be Part of..
Apertura: 0,0151 Min: 0,0111 Max: 0,0177
Chiusura: 0,013846

La tua Cronologia

NASDAQ
CDTTW
Conduit Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci